Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults

Shigeo Hanada, Miyuki Morozumi, Yui Takahashi, Sayaka Mochizuki, Toshitaka Sato, Shinko Suzuki, Hironori Uruga, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Kimiko Ubukata, Kazuma Kishi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We herein describe a case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae (MRMP) in an adult who responded poorly to macrolide antibiotics, progressively deteriorated to acute respiratory failure and then responded effectively to a fluoroquinolone. In a series of 14 patients with M. pneumoniae pneumonia, 11 were infected with MRMP. In seven of the eight cases of MRMP initially treated with macrolides, the patients did not improve, and a marked improvement was observed only after the antibiotic regimen was modified to include fluoroquinolones or tetracyclines. Nationwide surveillance should provide important information regarding the prevalence and empirical treatment of MRMP infection in adults.

Original languageEnglish
Pages (from-to)1675-1678
Number of pages4
JournalInternal Medicine
Volume53
Issue number15
DOIs
Publication statusPublished - 2014

Fingerprint

Mycoplasma pneumoniae
Macrolides
Pneumonia
Fluoroquinolones
Mycoplasma Pneumonia
Anti-Bacterial Agents
Tetracyclines
Respiratory Insufficiency
Infection

Keywords

  • Community-acquired pneumonia
  • Macrolide
  • Mycoplasma pneumoniae

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Hanada, S., Morozumi, M., Takahashi, Y., Mochizuki, S., Sato, T., Suzuki, S., ... Kishi, K. (2014). Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults. Internal Medicine, 53(15), 1675-1678. https://doi.org/10.2169/internalmedicine.53.1418

Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults. / Hanada, Shigeo; Morozumi, Miyuki; Takahashi, Yui; Mochizuki, Sayaka; Sato, Toshitaka; Suzuki, Shinko; Uruga, Hironori; Takaya, Hisashi; Miyamoto, Atsushi; Morokawa, Nasa; Ubukata, Kimiko; Kishi, Kazuma.

In: Internal Medicine, Vol. 53, No. 15, 2014, p. 1675-1678.

Research output: Contribution to journalArticle

Hanada, S, Morozumi, M, Takahashi, Y, Mochizuki, S, Sato, T, Suzuki, S, Uruga, H, Takaya, H, Miyamoto, A, Morokawa, N, Ubukata, K & Kishi, K 2014, 'Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults', Internal Medicine, vol. 53, no. 15, pp. 1675-1678. https://doi.org/10.2169/internalmedicine.53.1418
Hanada, Shigeo ; Morozumi, Miyuki ; Takahashi, Yui ; Mochizuki, Sayaka ; Sato, Toshitaka ; Suzuki, Shinko ; Uruga, Hironori ; Takaya, Hisashi ; Miyamoto, Atsushi ; Morokawa, Nasa ; Ubukata, Kimiko ; Kishi, Kazuma. / Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults. In: Internal Medicine. 2014 ; Vol. 53, No. 15. pp. 1675-1678.
@article{4f5c3d3bc9cc4cc2ab147c3bea1720c8,
title = "Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults",
abstract = "We herein describe a case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae (MRMP) in an adult who responded poorly to macrolide antibiotics, progressively deteriorated to acute respiratory failure and then responded effectively to a fluoroquinolone. In a series of 14 patients with M. pneumoniae pneumonia, 11 were infected with MRMP. In seven of the eight cases of MRMP initially treated with macrolides, the patients did not improve, and a marked improvement was observed only after the antibiotic regimen was modified to include fluoroquinolones or tetracyclines. Nationwide surveillance should provide important information regarding the prevalence and empirical treatment of MRMP infection in adults.",
keywords = "Community-acquired pneumonia, Macrolide, Mycoplasma pneumoniae",
author = "Shigeo Hanada and Miyuki Morozumi and Yui Takahashi and Sayaka Mochizuki and Toshitaka Sato and Shinko Suzuki and Hironori Uruga and Hisashi Takaya and Atsushi Miyamoto and Nasa Morokawa and Kimiko Ubukata and Kazuma Kishi",
year = "2014",
doi = "10.2169/internalmedicine.53.1418",
language = "English",
volume = "53",
pages = "1675--1678",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "15",

}

TY - JOUR

T1 - Community-acquired pneumonia caused by macrolide-resistant mycoplasma pneumoniae in adults

AU - Hanada, Shigeo

AU - Morozumi, Miyuki

AU - Takahashi, Yui

AU - Mochizuki, Sayaka

AU - Sato, Toshitaka

AU - Suzuki, Shinko

AU - Uruga, Hironori

AU - Takaya, Hisashi

AU - Miyamoto, Atsushi

AU - Morokawa, Nasa

AU - Ubukata, Kimiko

AU - Kishi, Kazuma

PY - 2014

Y1 - 2014

N2 - We herein describe a case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae (MRMP) in an adult who responded poorly to macrolide antibiotics, progressively deteriorated to acute respiratory failure and then responded effectively to a fluoroquinolone. In a series of 14 patients with M. pneumoniae pneumonia, 11 were infected with MRMP. In seven of the eight cases of MRMP initially treated with macrolides, the patients did not improve, and a marked improvement was observed only after the antibiotic regimen was modified to include fluoroquinolones or tetracyclines. Nationwide surveillance should provide important information regarding the prevalence and empirical treatment of MRMP infection in adults.

AB - We herein describe a case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae (MRMP) in an adult who responded poorly to macrolide antibiotics, progressively deteriorated to acute respiratory failure and then responded effectively to a fluoroquinolone. In a series of 14 patients with M. pneumoniae pneumonia, 11 were infected with MRMP. In seven of the eight cases of MRMP initially treated with macrolides, the patients did not improve, and a marked improvement was observed only after the antibiotic regimen was modified to include fluoroquinolones or tetracyclines. Nationwide surveillance should provide important information regarding the prevalence and empirical treatment of MRMP infection in adults.

KW - Community-acquired pneumonia

KW - Macrolide

KW - Mycoplasma pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=84905227030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905227030&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.53.1418

DO - 10.2169/internalmedicine.53.1418

M3 - Article

C2 - 25088885

AN - SCOPUS:84905227030

VL - 53

SP - 1675

EP - 1678

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 15

ER -